Nutanix, Inc. (NTNX) stock
NTNXNasdaqServices-Prepackaged SoftwareFiscal year ends July 31
Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Sep 18, 2026Score 14/30100% below fair value
$60.38−0.49 (-0.80%)
Close on Nov 13, 2026Market cap $16.34BP/E –Yield –
Nutanix EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Nutanix's EPS for the twelve months ending Apr 30, 2021 was -$4.26. For fiscal 2026 it was $5.17, up 695.4% from the year before. The highest annual figure on record is $5.17 in fiscal 2026.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jul 31, 2026 | $5.17 | +695.4% |
| FY2025 | Jul 31, 2025 | $0.65 | – |
| FY2024 | Jul 31, 2024 | -$0.51 | – |
| FY2023 | Jul 31, 2023 | -$1.09 | – |
| FY2022 | Jul 31, 2022 | -$3.62 | – |
| FY2021 | Jul 31, 2021 | -$5.02 | – |
| FY2020 | Jul 31, 2020 | -$4.48 | – |
| FY2019 | Jul 31, 2019 | -$3.43 | – |
| FY2018 | Jul 31, 2018 | -$1.81 | – |
| FY2017 | Jul 31, 2017 | -$2.96 | – |
| FY2016 | Jul 31, 2016 | -$2.46 | – |
| FY2015 | Jul 31, 2015 | -$3.11 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ1 2026 | Apr 30, 2026 | $0.25 | +31.6% |
| Q2 FY2026CQ4 2025 | Jan 31, 2026 | $0.36 | +260.0% |
| Q1 FY2026CQ3 2025 | Oct 31, 2025 | $0.21 | – |
| Q3 FY2025CQ1 2025 | Apr 30, 2025 | $0.22 | +83.3% |
| Q2 FY2025CQ4 2024 | Jan 31, 2025 | $0.19 | – |
| Q1 FY2025CQ3 2024 | Oct 31, 2024 | $0.10 | – |
| Q3 FY2024CQ1 2024 | Apr 30, 2024 | -$0.06 | – |
| Q2 FY2024CQ4 2023 | Jan 31, 2024 | $0.12 | – |
| Q1 FY2024CQ3 2023 | Oct 31, 2023 | -$0.07 | – |
| Q3 FY2023CQ1 2023 | Apr 30, 2023 | -$0.30 | – |
| Q2 FY2023CQ4 2022 | Jan 31, 2023 | -$0.31 | – |
| Q1 FY2023CQ3 2022 | Oct 31, 2022 | -$0.44 | – |
| Q3 FY2022CQ1 2022 | Apr 30, 2022 | -$0.50 | – |
| Q2 FY2022CQ4 2021 | Jan 31, 2022 | -$0.53 | – |
| Q1 FY2022CQ3 2021 | Oct 31, 2021 | -$1.95 | – |
| Q3 FY2021CQ1 2021 | Apr 30, 2021 | -$0.60 | – |
| Q2 FY2021CQ4 2020 | Jan 31, 2021 | -$1.42 | – |
| Q1 FY2021CQ3 2020 | Oct 31, 2020 | -$1.31 | – |
| Q4 FY2020CQ2 2020 | Jul 31, 2020 | -$0.93 | – |
| Q3 FY2020CQ1 2020 | Apr 30, 2020 | -$1.23 | – |
| Q2 FY2020CQ4 2019 | Jan 31, 2020 | -$1.13 | – |
| Q1 FY2020CQ3 2019 | Oct 31, 2019 | -$1.21 | – |
| Q4 FY2019CQ2 2019 | Jul 31, 2019 | -$1.04 | – |
| Q3 FY2019CQ1 2019 | Apr 30, 2019 | -$1.15 | – |
| Q2 FY2019CQ4 2018 | Jan 31, 2019 | -$0.68 | – |
| Q1 FY2019CQ3 2018 | Oct 31, 2018 | -$0.54 | – |
| Q4 FY2018CQ2 2018 | Jul 31, 2018 | -$0.51 | – |
| Q3 FY2018CQ1 2018 | Apr 30, 2018 | -$0.51 | – |
| Q2 FY2018CQ4 2017 | Jan 31, 2018 | -$0.39 | – |
| Q1 FY2018CQ3 2017 | Oct 31, 2017 | -$0.39 | – |
| Q4 FY2017CQ2 2017 | Jul 31, 2017 | -$0.43 | – |
| Q3 FY2017CQ1 2017 | Apr 30, 2017 | -$0.67 | – |
| Q2 FY2017CQ4 2016 | Jan 31, 2017 | -$0.54 | – |
| Q1 FY2017CQ3 2016 | Oct 31, 2016 | -$1.89 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?